Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Javier San Martin Insider Profile
4 Followers
Javier San Martin, CMO at Arrowhead Pharmaceuticals, holds 198.50K shares in Arrowhead Pharmaceuticals (Ticker: ARWR), holds ― shares in Athira Pharma (Ticker: ATHA).
Javier San Martin has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Javier San Martin holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Nov 22, 2023 - Today
Return:+24.40%
The most profitable trade made by Javier San Martin
Javier San Martin's Trading History
Arrowhead Pharmaceuticals
Jan 08, 2024
CMO
Uninformative Buy
―
$3.71M
Athira Pharma
―
CMO
―
―
List of latest transactions for each holding click on a transaction to see Javier San Martin's performance on stock
You May Also Like
Javier San Martin insider profile FAQ
What is the percentage of profitable transactions made by Javier San Martin?
The percentage of profitable transactions made by Javier San Martin is ―.
What is the average return per transaction made by Javier San Martin?
The average return per transaction made by Javier San Martin is ―.
What stocks does Javier San Martin hold?
Javier San Martin holds: ARWR, ATHA stocks.
What was Javier San Martin’s latest transaction?
Javier San Martin latest transaction was an Uninformative Buy of ―.
What was Javier San Martin's most profitable transaction?
Javier San Martin’s most profitable transaction was an Informative Sell of ARWR stock on November 22, 2023. The return on the trade was 24.40%.
What is Javier San Martin's role in Arrowhead Pharmaceuticals?
Javier San Martin's role in Arrowhead Pharmaceuticals is CMO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.